Fluid Overload: Clinical Trials

10 trials for Fluid Overload, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 terminated, 1 recruiting, 1 withdrawn. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 4, Terminated 4, Recruiting 1, Withdrawn 1

Follow Fluid Overload: new trials by email Literature Review of Fluid Overload trials Research Report on Fluid Overload

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure
Extended Release Torsemide Tablets, Immedate Release Torsemide Tablets - Heart Failure, Edema
Phase 4WithdrawnSarfez Pharmaceuticals, Inc.2025-05-012026-09-28
Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.
Furosemide, Isotonic saline - Fluid Overload
Phase 4RecruitingMorten H. Bestle10002020-08-172026-06-03
Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients
Furosemide Injection, Albumin Human - Cirrhosis, Liver, Volume Overload
Phase 4TerminatedRush University Medical Center212019-12-192025-09-16
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
Metolazone 60 minutes prior to furosemide, Metolazone concurrently with furosemide - Fluid Overload, Heart Failure Acute
Phase 4TerminatedUniversity of Maryland, Baltimore32019-01-012021-10-22
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
Vitamin C, Hydrocortisone, Thiamine - Sepsis, Septic Shock
Phase 4TerminatedUniversity Medical Centre Ljubljana52017-09-262019-02-19
TOnicity of Perioperative Maintenance SoluTions
NaCl 0.9% in Glucose 5% + 40mmol/L Potassium, Glucion 5% - Thoracic Diseases, Water-Electrolyte Imbalance
Phase 4CompletedNiels Van Regenmortel702017-03-092018-08-14
Forced Fluid Removal in High Risk Acute Kidney Injury
Furosemide (Furix), Continuous renal replacement therapy (CRRT), Resuscitation - Acute Kidney Injury, Fluid Overload
Phase 4TerminatedNordsjaellands Hospital212015-10-012017-07-06
Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury
(100 ml of Albumin 25%) - Hypotension During Dialysis, Fluid Overload
Phase 4CompletedUniversity of California, San Diego652015-06-032020-08-24
Crystalloids Versus Colloids During Surgery
Lactated Ringer's Solution, Hydroxyethylstarch 6% 130/0.4 - Fluid Overload, Postoperative Complications
Phase 4CompletedMedical University of Vienna11092006-09-012018-01-10
The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis
Bioelectrical impedance-guide dry weight reduction - Hypertension, Fluid Overload
Phase 4CompletedTaipei Veterans General Hospital, Taiwan1322006-09-012009-02-27

Narrower conditions

Edema (10)  ·  Critical Illness (2)  ·  Acute Kidney Injury (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Hypernatremia (1)  ·  Hypertension (1)  ·  Liver Cirrhosis (1)  ·  Postoperative Complications (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Thoracic Diseases (1)  ·  Water-Electrolyte Imbalance (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (10)  ·  Pathologic Processes (5)  ·  Disease Attributes (3)  ·  Cardiovascular Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Renal Insufficiency (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Chronic Disease (1)

Interventions

Furosemide (4)  ·  Sodium Chloride (2)  ·  Adrenal Cortex Hormones (1)  ·  Albumins (1)  ·  Ascorbic Acid (1)  ·  Continuous Renal Replacement Therapy (1)  ·  Glucose (1)  ·  Hydrocortisone (1)  ·  Hydroxyethyl Starch Derivatives (1)  ·  Metolazone (1)  ·  Potassium (1)  ·  Resuscitation (1)  ·  Ringer's Lactate (1)  ·  Saline Solution (1)  ·  Serum Albumin, Human (1)

Sponsors

Medical University of Vienna (1)  ·  Morten H. Bestle (1)  ·  Niels Van Regenmortel (1)  ·  Nordsjaellands Hospital (1)  ·  Rush University Medical Center (1)  ·  Sarfez Pharmaceuticals, Inc. (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  University Medical Centre Ljubljana (1)  ·  University of California, San Diego (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (3)  ·  Denmark (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Czechia (1)  ·  Finland (1)  ·  Iceland (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Slovenia (1)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Anders Perner, Md, Ph D (1)  ·  Brent Reed, PharmD (1)  ·  Edith Fleischmann, M.D., Ph.D. (1)  ·  Jens-Ulrik Jensen, MD, Ph D (1)  ·  Jinn-Yang Chen, MD, PhD (1)  ·  Lance Lance Lineberger, PharmD (1)  ·  Michael Ibsen, MD, Ph D (1)  ·  Morten Bestle, MD (1)  ·  Morten H Bestle, MD, Ph D (1)  ·  Rasmus E Berthelsen, MD (1)  ·  Ravindra L Mehta, MD (1)  ·  Salim Shah, PhD, JD (1)  ·  Sebastian Stefanovic, MD (1)

Results publications

PMID 28438182, PMID 29664109, PMID 31627889, PMID 32825817, PMID 33407747, PMID 35898170, PMID 37691474, PMID 38622671

NIH funding

2015 (1), 2019 (1)